Trial Profile
A randomized open-label, multinational, multicentre, phase III clinical study to evaluate the efficacy and safety of Ibuprofen oral suspension 20 mg/ml and Ibuprofen oral suspension 40 mg/ml (Berlin-Chemie) compared with Nurofen oral suspension 20 mg/ml (Reckitt Benckiser) in children 3-9 years old with uncomplicated acute otitis media
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- Sponsors Berlin Chemie
- 08 Mar 2016 New trial record